Circio Holding ASA
Clinical-stage company developing circular RNA medicines and immunotherapies.
CRNA | OL
Overview
Corporate Details
- ISIN(s):
- NO0012858564 (+5 more)
- LEI:
- 5967007LIEEXZXFYNS31
- Country:
- Norway
- Address:
- Vollsveien 19, 1366 Lysaker
- Website:
- https://www.targovax.com/en/
Description
Circio Holding ASA is a clinical-stage company developing novel medicines based on circular RNA (circRNA) and immunotherapy. The company's core focus is its proprietary circVec platform, a circular RNA expression system designed to enhance the efficacy and durability of gene and cell therapies. Circio's development pipeline is directed towards immuno-oncology, targeting difficult-to-treat solid tumors, and the application of its circRNA technology to address genetic diseases.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Type / Size | Actions | |
|---|---|---|---|---|---|
| 2025-07-04 09:22 |
Circio Holding ASA: Registration of share capital increase following conversion…
|
Norwegian | HTML • 2.5 KB | ||
| 2025-06-30 21:49 |
Circio Holding ASA: Requested Conversion of Convertible Bonds
|
English | HTML • 2.8 KB | ||
| 2025-06-30 07:00 |
NeoRegen Biotech and Circio advance circular RNA delivery collaboration into in…
|
English | HTML • 6.1 KB | ||
| 2025-06-20 11:01 |
Circio Holding ASA: Registration of share capital increase following conversion…
|
Norwegian | HTML • 2.6 KB | ||
| 2025-06-18 16:57 |
Flaggemelding Star Kapital AS - Circio Holding ASA
|
Norwegian | HTML • 853 bytes | ||
| 2025-06-17 17:17 |
Circio Holding ASA - Funding requested under financing commitment from Atlas
|
English | HTML • 2.8 KB | ||
| 2025-06-17 13:48 |
Circio Holding ASA: Requested Conversion of Convertible Bonds
|
English | HTML • 3.5 KB | ||
| 2025-06-16 07:00 |
TG01 mutant RAS cancer vaccine data showing clinical benefit in multiple myelom…
|
English | PDF • 593.2 KB | ||
| 2025-06-16 07:00 |
TG01 mutant RAS cancer vaccine data showing clinical benefit in multiple myelom…
|
English | HTML • 7.2 KB | ||
| 2025-06-06 09:53 |
Circio Holding ASA: Registration of share capital increase following conversion…
|
English | HTML • 2.7 KB | ||
| 2025-06-05 13:49 |
Circio Holding ASA: Minutes from the annual general meeting 2025 - Attachment: …
|
English | PDF • 870.6 KB | ||
| 2025-06-05 13:49 |
Circio Holding ASA: Minutes from the annual general meeting 2025
|
English | HTML • 2.9 KB | ||
| 2025-06-04 22:00 |
Circio Holding ASA: Requested Conversion of Convertible Bonds
|
English | HTML • 3.5 KB | ||
| 2025-05-28 07:00 |
Circio presents new and differentiating circVec data and corporate update in li…
|
English | PDF • 2.7 MB | ||
| 2025-05-28 07:00 |
Circio presents new and differentiating circVec data and corporate update in li…
|
English | HTML • 6.0 KB |
Automate Your Workflow. Get a real-time feed of all Circio Holding ASA filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Circio Holding ASA
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Circio Holding ASA via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
